XBiotech (XBIT) EBT (2014 - 2026)
XBiotech (XBIT) posted quarterly EBT of -$26.8 million for Q4 2025, down 154.2% year-over-year from $49.5 million in Q4 2024, and down 354.05% quarter-over-quarter from -$5.9 million in Q3 2025.
XBiotech (XBIT) EBT (2014 - 2026) Analysis & Trends
XBiotech's EBT history runs 12 years deep, the most recent figure standing at -$26.8 million for Q4 2025.
- In Q4 2025, EBT fell 154.2% year-over-year to -$26.8 million; the TTM figure through Dec 2025 stood at -$45.3 million (down 17.48% YoY), while the FY2025 annual figure was -$45.3 million, down 17.48% from the prior year.
- EBT for Q4 2025 stood at -$26.8 million, down from -$5.9 million in the prior quarter.
- The five-year high for EBT was -$1.7 million in Q2 2025, with the low at -$26.8 million in Q4 2025.
- The 5-year median for EBT is -$7.4 million (2021), against an average of -$8.4 million.
- The sharpest annual moves came in 2021 and 2025: EBT tumbled 731.97% in 2021, then surged 86.74% in 2025.
- XBiotech's EBT stood at -$7.7 million in 2021, then surged by 65.77% to -$2.6 million in 2022, then plunged by 80.34% to -$4.7 million in 2023, then slumped by 122.83% to -$10.5 million in 2024, then slumped by 154.2% to -$26.8 million in 2025.
- Business Quant data shows XBIT's EBT at -$26.8 million in Q4 2025, -$5.9 million in Q3 2025, and -$1.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | -6.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.68 Mn |
| Dec 31, 2025 | -26.82 Mn |
| Sep 30, 2025 | -5.91 Mn |
| Jun 30, 2025 | -1.73 Mn |
| Mar 31, 2025 | -10.86 Mn |
| Dec 31, 2024 | -10.55 Mn |
| Sep 30, 2024 | -5.01 Mn |
| Jun 30, 2024 | -13.03 Mn |
| Mar 31, 2024 | -9.98 Mn |
| Dec 31, 2023 | -4.73 Mn |
| Sep 30, 2023 | -7.06 Mn |
| Jun 30, 2023 | -8.67 Mn |
| Mar 31, 2023 | -3.85 Mn |
| Dec 31, 2022 | -2.63 Mn |
| Sep 30, 2022 | -10.26 Mn |
| Jun 30, 2022 | -14.25 Mn |
| Mar 31, 2022 | -6.45 Mn |
| Dec 31, 2021 | -7.67 Mn |
| Sep 30, 2021 | -5.06 Mn |
| Jun 30, 2021 | -9.69 Mn |